Suppr超能文献

多模态分子影像学:现状与未来方向。

Multimodal Molecular Imaging: Current Status and Future Directions.

机构信息

Department of Radiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.

出版信息

Contrast Media Mol Imaging. 2018 Jun 5;2018:1382183. doi: 10.1155/2018/1382183. eCollection 2018.

Abstract

Molecular imaging has emerged at the end of the last century as an interdisciplinary method involving imaging and molecular biology aiming at identifying living biological processes at a cellular and molecular level in a noninvasive manner. It has a profound role in determining disease changes and facilitating drug research and development, thus creating new medical modalities to monitor human health. At present, a variety of different molecular imaging techniques have their advantages, disadvantages, and limitations. In order to overcome these shortcomings, researchers combine two or more detection techniques to create a new imaging mode, such as multimodal molecular imaging, to obtain a better result and more information regarding monitoring, diagnosis, and treatment. In this review, we first describe the classic molecular imaging technology and its key advantages, and then, we offer some of the latest multimodal molecular imaging modes. Finally, we summarize the great challenges, the future development, and the great potential in this field.

摘要

分子影像学是上个世纪末出现的一种涉及影像学和分子生物学的交叉学科方法,旨在非侵入性地在细胞和分子水平上识别活体的生物学过程。它在确定疾病变化、促进药物研发方面具有重要作用,从而创造了新的医学模式来监测人类健康。目前,各种不同的分子影像学技术都有其优缺点和局限性。为了克服这些缺点,研究人员将两种或更多种检测技术结合起来,创造出新的成像模式,如多模态分子成像,以获得更好的结果和更多关于监测、诊断和治疗的信息。在这篇综述中,我们首先描述了经典的分子成像技术及其关键优势,然后介绍了一些最新的多模态分子成像模式。最后,我们总结了该领域面临的巨大挑战、未来发展和巨大潜力。

相似文献

1
Multimodal Molecular Imaging: Current Status and Future Directions.
Contrast Media Mol Imaging. 2018 Jun 5;2018:1382183. doi: 10.1155/2018/1382183. eCollection 2018.
2
Multimodal nanoparticle imaging agents: design and applications.
Philos Trans A Math Phys Eng Sci. 2017 Nov 28;375(2107). doi: 10.1098/rsta.2017.0261.
3
Advances in PET: The success of multimodal molecular imaging.
Med Clin (Barc). 2017 Apr 21;148(8):354-356. doi: 10.1016/j.medcli.2016.11.020. Epub 2016 Dec 27.
4
Toward Molecular Imaging of Intestinal Pathology.
Inflamm Bowel Dis. 2020 Sep 18;26(10):1470-1484. doi: 10.1093/ibd/izaa213.
5
Recent advances in molecular imaging of atherosclerotic plaques and thrombosis.
Nanoscale. 2020 Apr 21;12(15):8040-8064. doi: 10.1039/d0nr00599a. Epub 2020 Apr 2.
6
Recent development of nanoparticles for molecular imaging.
Philos Trans A Math Phys Eng Sci. 2017 Nov 28;375(2107). doi: 10.1098/rsta.2017.0022.
7
Multimodal techniques and strategies for chemical and metabolic imaging at the single-cell level.
Curr Opin Biotechnol. 2024 Aug;88:103149. doi: 10.1016/j.copbio.2024.103149. Epub 2024 May 28.
8
Current status and future challenges for molecular imaging.
Philos Trans A Math Phys Eng Sci. 2017 Nov 28;375(2107). doi: 10.1098/rsta.2017.0023.
9
Optical and multimodal peptide-based probes for in vivo molecular imaging.
Anticancer Agents Med Chem. 2012 Jun;12(5):476-99. doi: 10.2174/187152012800617858.

引用本文的文献

2
Advancements in molecular imaging for the diagnosis and treatment of pancreatic ductal adenocarcinoma.
Nanoscale Adv. 2025 Apr 22;7(10):2887-2903. doi: 10.1039/d4na01080a. eCollection 2025 May 13.
3
Multimodal Mass Spectrometry Imaging in Atlas Building: A Review.
Semin Nephrol. 2024 Nov;44(6):151578. doi: 10.1016/j.semnephrol.2025.151578. Epub 2025 Apr 16.
7
Application of rare earth elements in dual-modality molecular probes.
RSC Adv. 2024 Dec 5;14(52):38480-38490. doi: 10.1039/d4ra04987j. eCollection 2024 Dec 3.
8
Unveiling Invisible Extracellular Vesicles: Cutting-Edge Technologies for Their in Vivo Visualization.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Sep-Oct;16(5):e2009. doi: 10.1002/wnan.2009.
9
Iodinated gadolinium-gold nanomaterial as a multimodal contrast agent for cartilage tissue imaging.
APL Bioeng. 2024 Aug 19;8(3):036110. doi: 10.1063/5.0215273. eCollection 2024 Sep.
10
Combining Nuclear Medicine With Other Modalities: Future Prospect for Multimodality Imaging.
Mol Imaging. 2024 Apr 30;23:15353508241245265. doi: 10.1177/15353508241245265. eCollection 2024 Jan-Dec.

本文引用的文献

1
Thyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles.
Contrast Media Mol Imaging. 2018 Mar 8;2018:8710862. doi: 10.1155/2018/8710862. eCollection 2018.
2
Deep Learning in Nuclear Medicine and Molecular Imaging: Current Perspectives and Future Directions.
Nucl Med Mol Imaging. 2018 Apr;52(2):109-118. doi: 10.1007/s13139-017-0504-7. Epub 2017 Nov 16.
3
Radioiodinated Small-Molecule Tyrosine Kinase Inhibitor for HER2-Selective SPECT Imaging.
J Nucl Med. 2018 Sep;59(9):1386-1391. doi: 10.2967/jnumed.117.205088. Epub 2018 Apr 13.
5
Iodinated Echogenic Glycol Chitosan Nanoparticles for X-ray CT/US Dual Imaging of Tumor.
Nanotheranostics. 2018 Jan 1;2(2):117-127. doi: 10.7150/ntno.18643. eCollection 2018.
8
Diagnosis of non-osseous spinal metastatic disease: the role of PET/CT and PET/MRI.
J Neurooncol. 2018 Jun;138(2):221-230. doi: 10.1007/s11060-018-2794-8. Epub 2018 Feb 26.
9
Hybrid SPECT/CT Imaging in the Management of Differentiated Thyroid Carcinoma.
Asian Pac J Cancer Prev. 2018 Feb 26;19(2):303-308. doi: 10.22034/APJCP.2018.19.2.303.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验